ExploreWatchlistsPricing
  1. JP-listed companies
  2. KAKEN PHARMACEUTIAL CO., LTD.
  3. Financials
  4. Net income margin (%)

KAKEN PHARMACEUTIAL CO., LTD. (4521)

Market cap
¥191.8B
P/E ratio
68.7x
A Japanese pharmaceutical company that manufactures and sells medicines, medical devices, and agricultural chemicals while also operating real estate leasing.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndNet income margin (%) YoY (%)
Mar 31, 202514.8+33.13%
Mar 31, 202411.1+49.44%
Mar 31, 20237.5-40.65%
Mar 31, 202212.6-29.75%
Mar 31, 202117.9-17.64%
Mar 31, 202021.7+15.00%
Mar 31, 201918.9-2.43%
Mar 31, 201819.3-10.83%
Mar 31, 201721.7+12.60%
Mar 31, 201619.3+49.24%
Mar 31, 201512.9+22.23%
Mar 31, 201410.6+6.50%
Mar 31, 20139.9+9.81%
Mar 31, 20129

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat